Variant · Snv
AK2 NM_001625.4(AK2):c.219+19A>G
CI-VAR-00066419Explore in graph →NM_001625.4:c.219+19A>GClinVar 418001 rs148975919
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 418001 | Conflicting classifications of pathogenicity | criteria provided, conflicting classifications | 1 | Reticular dysgenesis; Ovarian serous cystadenocarcinoma; Lung cancer; Familial cancer of breast; Uveal melanoma; Gastric cancer; Acute myeloid leukemia; Cervical cancer | germline | 4 | Feb 04, 2026 | clinvar |